GenomSys Announces Exclusive Software Distribution Agreement in Jordan with Genetics Company for Biotechnology

Press Release Β· May 2026 Β· Geneva, Switzerland & Amman, Jordan

 

A strategic partnership to advance genomic medicine, MPEG-G adoption, and precision diagnostics across the Middle East

A Landmark Agreement for Genomic Innovation

GenomSys, the Swiss company behind the world’s first commercial implementation of the ISO/IEC 23092 MPEG-G standard for genomic data management, is proud to announce the signing of an exclusive software distribution agreement in Jordan with Genetics Company for Biotechnology, one of the region’s most respected molecular biology and genomics service providers.

This agreement marks a pivotal step in the international expansion of GenomSys and in the mission to bring next-generation genomic data technologies to healthcare systems across the Middle East and beyond.

“This partnership reflects our shared commitment to making advanced genomic tools accessible to clinicians and researchers in Jordan and the wider region β€” enabling faster, more accurate, and more cost-effective precision medicine.”

About Genetics Company for Biotechnology

Founded in 2009 and headquartered in Amman, Jordan, Genetics Company for Biotechnology is a pioneer in Next-Generation Sequencing (NGS), molecular biology, and genomic diagnostics for the Middle East. With a team of highly qualified scientists and state-of-the-art laboratory infrastructure, the company offers a comprehensive portfolio of services spanning clinical genetics, pharmacogenomics, oncology genomics, and infectious disease diagnostics.

Genetics Company serves hospitals, research institutions, and public health agencies across Jordan and neighboring countries, and is recognized as a trusted partner for cutting-edge genomic science in the Arab world.

Core Expertise: Next-Generation Sequencing, molecular diagnostics, clinical genetics, oncology genomics, pharmacogenomics, and infectious disease profiling.

Regional Leadership: Serving hospitals, universities, and research centers across Jordan and the broader Middle East since 2009.

Strategic Goals of the Partnership

The collaboration between GenomSys and Genetics Company is built on three interconnected pillars designed to transform genomic data management and clinical genomics in Jordan:

🧬 MPEG-G Standard Adoption β€” Promote and implement the ISO/IEC 23092 MPEG-G standard as the unified framework for compressing, storing, transmitting, and accessing genomic data β€” replacing fragmented legacy formats.

πŸ₯ Preventive Medicine β€” Co-develop customized software solutions for preventive genomic medicine, enabling early disease detection, population screening, and personalized healthcare pathways in Jordan.

The two companies are jointly committed to building a genomic data ecosystem in Jordan aligned with international standards β€” reducing costs, improving interoperability, and unlocking the potential of precision medicine for the Jordanian population.

GenomSys Blood Typer: A Revolutionary Clinical Application

Central to this partnership is the joint development and clinical testing of the GenomSys Blood Typer β€” a groundbreaking software application that harnesses genomic analysis to provide highly accurate blood group typing in support of transfusion medicine and organ transplantation.

Unlike conventional serology-based methods, the Blood Typer uses whole-genome or targeted sequencing data to predict extended blood group antigens with exceptional precision β€” reducing the risk of transfusion reactions and improving compatibility matching for complex cases.

Clinical Impact: Enables accurate antigen profiling from genomic data β€” critical for patients with rare blood types, multiple alloantibodies, or complex transfusion histories.

Transplant Support: Provides precise HLA-related and blood group compatibility analysis to support organ and stem cell transplantation workflows in Jordanian hospitals.

Genetics Company will serve as the primary testing and validation partner for Blood Typer in the Jordanian clinical environment, accelerating its adoption in regional hospitals and transfusion centers.

About GenomSys and the MPEG-G Standard

GenomSys is a Swiss biotech software company and MPEG-G Competence Center, recognized internationally for its pioneering role in developing and commercializing the ISO/IEC 23092 standard β€” the only unified international standard for genomic data management.

The GenomSys product suite includes:

GS Toolkit β€” A complete SDK and command-line toolset for encoding, decoding, and managing genomic files in the MPEG-G format β€” enabling integration into any bioinformatics pipeline.

GenomSys Variant Analyzer (GVA) β€” An intuitive desktop application for clinical variant interpretation, supporting NGS data analysis with MPEG-G native support for maximum efficiency.

GenomYou β€” A consumer-facing genomics application enabling individuals to access, understand, and share their genomic data securely and in a standardized format.

 

Blood Typer β€” Next-generation genomic blood typing software for clinical transfusion and transplantation support β€” now being validated in Jordan with Genetics Company.

“The adoption of the MPEG-G standard in Jordan, enabled by our exclusive partnership with Genetics Company, represents a concrete step toward a more interoperable, efficient, and patient-centered genomic medicine ecosystem in the Middle East.”

β€” GenomSys Leadership Team

Looking Ahead

This exclusive distribution agreement is the foundation of a long-term strategic relationship. GenomSys and Genetics Company intend to collaborate on clinical studies, joint publications, regulatory submissions, and the progressive rollout of MPEG-G-based solutions across Jordanian healthcare institutions.

Together, the two companies aim to position Jordan as a regional hub for genomic innovation β€” bridging world-class Swiss biotech expertise with deep local knowledge and clinical networks in the Arab world.

For partnership inquiries, media requests, or further information about the agreement and GenomSys products, please contact: info@genomsys.com

May 2026 Β· GenomSys MPEG-G Competence Center Β· www.genomsys.com Β· info@genomsys.com Β· www.genetics-jo.com

Schedule a call

[contact-form-7 id="224" title="contact call"]